Healthcare stocks have gotten crushed in 2024, and next year doesn’t look much better. But there are still opportunities for ...
WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for ...
In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback